380
Views
9
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches

, , , , , & show all
Pages 2-14 | Received 28 Dec 2013, Accepted 16 Jun 2014, Published online: 15 Jul 2014

References

  • Marques IJ, Vaz PD, Fernandes AC, et al. Advantageous delivery of nifedipine from inorganic materials showing increased solubility and biocompatibility. Micropor Mesopor Mat 2014;183:192–200
  • Yuan XD, Sperger D, Munson EJ. Investigating miscibility and molecular mobility of Nifedipine-PVP amorphous solid dispersions using solid-state NMR spectroscopy. Molecular Pharm 2014;11:329–37
  • Ganesh CL, Patil KD, Ghodke D, et al. Preparation and characterization of solid dispersion tablet of furosemide with crospovidone. Res J Pharm Tech 2008;4:386–9
  • Sinha S, Ali M, Baboota A, et al. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech 2010;11:518–27
  • Han HK, Lee BJ, Lee HK. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation. Int J Pharm 2011;415:89–94
  • Brabander CD, Mooter GVD, Vervaet C, et al. Characterization of ibuprofen as a nontraditional plasticizer of ethyl cellulose. J Pharm Sci 2002;9:1678–85
  • Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107–17
  • Breitenbach J, Lewis J. Two concepts, one technology: controlled release and solid dispersion with meltrex. In: Rathbone MJ, Hadgraft J, Roberts MS, Lane ME, eds. Modified-release of drug delivery technology. New York: Marcel Dekker; 2003:125–34
  • Huang JJ, Wigent RJ, Schwartz JB. Nifedipine molecular dispersion inmicroparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for drug controlled delivery. Effect of matrix composition. Drug Dev Ind Pharm 2006;32:1185–97
  • James EP, James MB, Forster AH, et al. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm 2007;336:22–34
  • Won DH, Kim MS, Lee S, et al. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-SE precipitation process. Int J Pharm 2005;301:199–208
  • Chauhan B, Shimpi S, Paradkar A. Preparation and evaluation of gliben-clamidepolyglycolized glycerides solid dispersions with silicon dioxide by spraydrying technique. Eur J Pharm Sci 2005;26:219–30
  • Dong ZD, Chatterji A, Sandhu H, et al. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation. Int J Pharm 2008;355:141–9
  • Duncan QMC. Review: the mechanism of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131–44
  • Serajuddin AT. Solid dispersion of poorly water soluble drugs: early promises problems subsequent and recent breakthroughs. J Pharm Sci 1999;88:1058–66
  • Zajc N, Obreza A, Bele M, et al. Physical properties and dissolution behavior of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm 2005;291:51–8
  • Chan KLA, Fleming OS, Kazarian SG, et al. Polymorphism and devitrification of nifedipine under controlled humidity: a combined FT-Raman, IR and Raman microscopic investigation. J Raman Spectrosc 2004;35:353–9
  • Chutimaworapan S, Ritthidej GC, Yonemochi E, et al. Effect of water-soluble carriers on dissolution characteristics of Nifedipine solid dispersions. Drug Dev Ind Pharm 2000;26:1141–50
  • Cilurzo F, Minghetti P, Casiraghi A, et al. Characterization of nifedipine solid dispersions. Int J Pharm 2002;242:313–7
  • Tang XC, Pikal MJ, Taylor LS. A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers. Pharm Res 2002;19:477–83
  • Huang J, Li Y, Wigent RJ, et al. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers. Int J Pharm 2011;420:59–67
  • Aaltonen J1, Gordon KC, Strachan CJ, et al. Perspectives in the use of spectroscopy to characterise pharmaceutical solids. Int J Pharm 2008;364:159–69
  • Rumondor ACF, Taylor LS. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture. Mol Pharm 2010;7:477–90
  • Rumondor ACF, Marsac PJ, Stanford LA, et al. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol Pharm 2009;6:1492–505
  • Mukharya A, Chaudhary S, Mansuri N, et al. Solid-state characterization of lacidipine/PVP K(29/32) solid dispersion primed by SE co-evaporation. Int J Pharm Invest 2012;2:90–6
  • Gorajana A, Rajendran A, Dua K, et al. Preparation, characterization, and in vitro evaluation of nitrendipine solid dispersions. J Disper Sci Technol 2012;33:676–84
  • Hirasawa N, Ishise S, Miyata H, et al. Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier. Drug Dev Ind Pharm 2003;29:339–44
  • Bandarkar FS, Vavia PR. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in beta-cyclodextrin. Drug Dev Ind Pharm 2011;37:1318–28
  • Aggarwal AK, Singh S. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000. Drug Dev Ind Pharm 2011;37:1181–91
  • Fu JJ, Xu LS, Wang XL, et al. Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 2001;37:934–44
  • He HB, Yang R, Tang X, et al. In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm 2010;36:681–7
  • Garg A, Singh S, Rao VU, et al. Solid state interaction o raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate. Drug Dev Ind Pharm 2009;35:455–70
  • Liu H, Zhou LL, Wei LL, et al. Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical fluid technology. Drug Dev Ind Pharm 2007;33:959–66
  • Chen SJ, Zhu JB, Ma FQ, et al. Preparation and characterization of solid dispersions of dipyridarmole with a carrier “copolywidonum Plasdone (R) S-630”. Drug Dev Ind Pharm 2007;33:888–99
  • Ren FZ, Jing QF, Tang YH, et al. Characteristics of bicalutamide solid dispersions and improvement of the dissolution. Drug Dev Ind Pharm 2006;32:967–72
  • Li L, AbuBaker O, Shao ZZJ. Characterization of poly(ethyleneoxide) as a drug carrier in hot-melt extrusion. Drug Dev Ind Pharm 2006;32:991–1002
  • El-Badry M, Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev Ind Pharm 2006;32:141–50
  • Aaltonen J1, Gordon KC, Strachan CJ, et al. Perspectives in the use of spectroscopy to characterise pharmaceutical solids. Drug Dev Ind Pharm 2008;364:159–69
  • Mohammadreza K, Bagheri GA, Mehdi R, et al. Diagnosis of renal failure by infrared spectrometric analysis of human serum samples and soft independent modeling of class analogy. Microchemical J 2013;106:67–72
  • Massart DL, Kaufman L. The interpretation of analytical chemical data by the use of cluster analysis. New York: Wiley; 1983: vol. 273:75–101
  • Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1–12
  • Smikalla MM, Urbanetz NA. The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol. Eur J Pharm Biopharm 2007;66:106–20
  • Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691–8
  • Miyazaki T, Yoshioka S, Aso Y, et al. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J Pharm Sci 2004;93:2710–7
  • Gupta P, Thillagavathi R, Chakraborti AK, et al. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Mol Pharm 2005;2:384–91
  • Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacet-ate) in relation to indomethacin crys tallization. Pharm Res 1999;16:1722–8
  • Taylor LS, Zografi G. Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures. J Pharm Sci 1998;87:1615–21
  • Karavas E, Georgarakis E, Sigalas MP, et al. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactions. Eur J Pharm Biopharm 2007;66:334–7
  • Konno H, Taylor LS. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm Res 2008;25:969–78
  • Marsac PJ, Konno H, Taylor LS. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm Res 2006;23:2306–16
  • Tang XLC, Pikal MJ, Taylor LS. The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers. Pharm Res 2002;19:484–90
  • Rumondor ACF, Ivanisevic I, Bates S, et al. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res 2009;26:2523–34
  • Kestur US, Taylor LS. Role of polymer chemistry in influencing crystal growth rates from amorphous felodipine. Cryst Eng Commun 2010;12:2390–97
  • Chen C, Xie XB, Li Y, et al. Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions. Drug Dev Ind Pharm 2013;40:441–51
  • Datta S, Grant DJW. Crystal structures of drugs: advances in determination, prediction and engineering. Nat Rev Drug Discov 2004;3:42–57
  • Duan JZ, Riviere K, Marroum P. In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match? Pharm Res 2011;28:1144–56
  • Moore JW, Planner HH. Mathematical comparison of dissolution profiles. Pharm Technol 1996;20:64–74

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.